Ziegelhöffer A, Vrbjar N, Styk J, Breier A, Dzurba A, Ravingerová T
Institute for Heart Research, Slovak Academy of Sciences, Bratislava.
Mol Cell Biochem. 1995;147(1-2):129-37. doi: 10.1007/BF00944793.
Ischemic preconditioning of the heart is referred as a manifest increase in tolerance of the myocardium to otherwise damaging ischemic insult, achieved by one or few consequent initial short exposures to ischemia, each followed by reperfusion of the ischemic area. Several mechanisms such as opening of collateral vessels, the action of catecholamines, inositol phosphates, G-proteins and/or adenosine; inhibition of mitochondrial ATPase, the effects of different endogenous protective substances like heat stress or shock proteins, etc., are believed to cooperate in the mechanism of induction of preconditioning or in maintaining its effect. The present study is an attempt to extend the present knowledge about preconditioning from two aspects: i.) the peculiarities of energy equilibrium in preconditioned myocardium including adaptation of cardiac sarcolemmal ATPases to ischemia and/or hypoxia, and ii) participation of a new endogenous cardioprotective substance in the mechanism of preconditioning. The energy equilibrium in preconditioning is characterized by adaptation of cardiac energy demands to the capacity of energy production and delivery decreased by anaerobiosis and is manifested by constant ratios between ATP, ADP, AMP and the sum of ADN. Principles are proposed that may enable a prediction and mathematical modelling of the balanced energetic state in the preconditioned myocardium. These principles are based on thermodynamics and involve besides others a more economic handling of ATP by sarcolemmal ATPases. The latter enzymes adapt themselves to lowered availability of ATP by decreasing besides their Vmax also their values of Km (increase in the affinity) for ATP and some of them even adjust their activation energy (the anaerobiosis-induced elevation of Ea.t. is missing).(ABSTRACT TRUNCATED AT 250 WORDS)
心脏缺血预处理是指心肌对原本具有损伤性的缺血性损伤的耐受性明显增加,这是通过对心肌进行一次或几次连续的短暂缺血暴露,随后每次都对缺血区域进行再灌注来实现的。人们认为,诸如侧支血管开放、儿茶酚胺、肌醇磷酸、G蛋白和/或腺苷的作用;线粒体ATP酶的抑制,不同内源性保护物质如热应激或休克蛋白等的作用等多种机制,在预处理的诱导机制或维持其效果中共同发挥作用。本研究试图从两个方面扩展关于预处理的现有知识:i)预处理心肌能量平衡的特点,包括心肌肌膜ATP酶对缺血和/或缺氧的适应性,以及ii)一种新的内源性心脏保护物质在预处理机制中的参与。预处理中的能量平衡以心脏能量需求适应因无氧代谢而降低的能量产生和输送能力为特征,并以ATP、ADP、AMP与ADN总和之间的恒定比例表现出来。提出了一些原则,这些原则可能有助于对预处理心肌的能量平衡状态进行预测和数学建模。这些原则基于热力学,除其他外,还涉及肌膜ATP酶对ATP的更经济利用。后一种酶通过除了降低其Vmax外,还降低其对ATP的Km值(亲和力增加)来适应ATP可用性的降低,其中一些酶甚至调整其活化能(无氧代谢引起的Ea.t.升高不存在)。(摘要截短于250字)